STAT February 26, 2023
Brittany Trang

On Friday, the Food and Drug Administration issued an emergency authorization for the first at-home test that can detect flu and Covid-19 — but for the test’s maker, Lucira, the long-anticipated authorization may have taken too long. The company filed for bankruptcy on Feb. 22, directly blaming the “protracted” FDA authorization process for the over-the-counter combination test for its financial troubles.

“This is a major milestone for Lucira Health and for at-home diagnostics, and I can’t thank our employees and partners enough for seeing this through, and of course, for the FDA’s recognition,” said Lucira CEO Erik Engelson in a statement to STAT, making no mention of the company’s bankruptcy. At the time of publication, Lucira had not answered questions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The COVID inquiry report is an excellent guide to preparing for the next pandemic—health cuts put that at risk
A Moment Of Reckoning In The Fight Against HIV
The risk of a bird flu pandemic is rising
New 'how-to guide' for future rapid vaccine development
How This Year’s UN Climate Change Conference Tackled Public Health

Share This Article